breast tumours
Our cell model suggests that BCAR4-positive breast tumours are driven by ERBB2/ERBB3 signalling.
Our cell model suggests that <span class="gene" id="20859285-11-29-34">BCAR4</span>-positive <span class="disease" id="20859285-11-44-58">breast tumours</span> are driven by ERBB2/ERBB3 signalling.